Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Here's the Metal stock that BoFA Securities is expecting to see gains of 21%
Of the 21 analysts who have coverage on the APL Apollo Tubes stock, 19 have a "buy" rating and one each have "hold" and "sell" ratings.
Retail investors bet on these 10 small-cap stocks; they rally up to 185% in 3 months
Retail investors raised stakes in 195 Nifty Smallcap 500 stocks during the March 2026 quarter, with over 100 delivering 25-185% returns since April. Four stocks turned multibaggers, while Cemindia Projects, Apollo Micro Systems and Lloyds Engineering led the rally.
Apollo Hospitals among 8 largecap stocks hit 52-week highs, rally up to 12% in a month
Indian markets remained firm with Sensex closing higher, supporting momentum in largecap stocks. Eight companies, including Apollo Hospitals and Bosch, hit 52-week highs amid sustained buying interest. Gains of up to 12% in a month highlight strong investor confidence and continued bullish sentiment in select sectors.
Zydus partners with Guardant Health and Apollo Hospitals to introduce Shield MCD in India
Zydus Lifesciences and Guardant Health, Inc., a leading precision oncology company, have an exclusive agreement to make the Shield Multi-Cancer Detection (MCD) test available in India, for which Zydus has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the test in the territory.
Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test
Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.

Zydus Lifesciences, Apollo Hospitals partner to expand access to multi-cancer blood test in India
Zydus Lifesciences and Apollo Hospitals partner to expand access to Shield Multi-Cancer Detection blood test in India, screening 10 common cancers.

APL Apollo Tubes’ profitability in focus after volumes fail to impress
Weak demand, Dubai disruptions and steel price volatility dragged APL Apollo's Q1 volumes well below guidance, shifting investor focus to whether margins can hold up.

Rajesh Palviya of Axis Sec suggests Five-Star Business, Apollo Tyres, Exide Industries shares to buy today
Sensex and Nifty 50 surged on Friday, driven by IT stocks amid optimism from softer US jobs data. Nifty 50 rose 0.83% to 24,375.65, with 15 of 16 sectoral indices in the green, reflecting positive market sentiment despite ongoing global uncertainties.
Top Gainers & Losers on 2 July: Zensar Tech, TCS, Coforge, Apollo Tyres, Bharat Forge, Anant Raj among top gainers
Dalal Street saw gains for the second consecutive day, driven by technology stocks and easing crude oil prices. Nifty 50 rose 0.71% to 24,175, while the Sensex gained 0.75% to 77,502. The Nifty IT index surged 4.5%, marking its biggest gain since January.

APL Apollo Tubes Q1 sales volume falls 6% amid softer dispatches
APL Apollo Tubes reported a 6% year-on-year decline in Q1FY27 sales volume to 7.45 lakh tonnes, while introducing a revised product segmentation framework to improve business reporting.
Apollo Hospital Share Price Live Updates: Apollo Hospital's Stock Shows Weekly Growth

Apollo Tyres shares gain after Kotak upgrade; check revised target price
Apollo Tyres has underperformed its peers over the past two years due to a loss of market share in the truck and bus radial (TBR) segment and the absence of operating leverage, which has weighed on margins.